Subscribe Now Subscribe Today
Research Article
 

Asymptomatic Bacteriuria among Type 2 Diabetics in the Sekondi-takoradi Metropolis, Ghana



Samuel A. Sakyi, Richard K.D. Ephraim, Bastu O. Adebisi, James O-Yeboah and Gifty Osei-Berchie
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail
ABSTRACT

Type 2 diabetes mellitus (T2DM) is associated with several overt and covert complications. The objective of this study was to establish the prevalence of Asymptomatic Bacteriuria (ASB), Antimicrobial Sensitivity pattern of the bacterial isolates and associated confounding factors leading to ASB in the Sekondi-takoradi metropolis. A cross-sectional, non-probability sampling technique was used to recruit 102 confirmed Type 2 diabetes mellitus and 23 healthy controls. Fasting blood samples were collected from both study and control participants for blood sugar analysis, midstream urine for microscopy, culture and Antibiotic Sensitivity Testing (AST). Total prevalence of ASB in this study was 26.4 with 41.9% of the total prevalence found in participants with 6-10 years of diabetic history yielding a comparative significant difference in ASB in patients with longer diabetic duration. E. coli was the most prevalent bacterial isolate (15.6%) and the most resistant (62.5-100%). Tetracycline and cotrimoxazole were the least effective drugs (0%) whilst nitrofurantoin, nalidixic and gentamicin were more effective. The peak incidence of ASB in T2DM occurs within age group 50-59 years and more frequently in female diabetics. T2DM patients significantly have abnormal Body Mass Index (BMI) (p = 0.0022). Age, sex and BMI predispose T2DM patients to prevalence of ASB with highly resistant isolates in the Sekondi-Takoradi metropolis. These must be factored in the treatment of T2DM complications.

Services
Related Articles in ASCI
Search in Google Scholar
View Citation
Report Citation

 
  How to cite this article:

Samuel A. Sakyi, Richard K.D. Ephraim, Bastu O. Adebisi, James O-Yeboah and Gifty Osei-Berchie, 2013. Asymptomatic Bacteriuria among Type 2 Diabetics in the Sekondi-takoradi Metropolis, Ghana. Journal of Medical Sciences, 13: 290-295.

DOI: 10.3923/jms.2013.290.295

URL: https://scialert.net/abstract/?doi=jms.2013.290.295
 
Received: January 28, 2013; Accepted: March 18, 2013; Published: May 21, 2013



INTRODUCTION

Diabetes mellitus is an endocrine disorder associated with micro and macro vascular complications. Additionally, diabetes are more susceptible to infections like Urinary Tract Infections (UTI) as the high glucose concentration in the urine of diabetics serves as a culture medium for pathogenic organisms (Carton et al., 1992; Pozzilli and Leslie, 1994). UTI in diabetics has always been associated with serious kidney infections such as renal papillary necrosis, emphysematous cystitis and pyelonephritis (Nicolle, 2000).

UTI can be asymptomatic or symptomatic but as to which one takes precedence is still a matter of debate (Alebiosu et al., 2003). Asymptomatic bacteriuria (ASB) is known to be higher in diabetics than non-diabetics (Zhanel et al., 1991). A number of risk factors including age, sexual intercourse and duration of diabetes have been mentioned (Nicolle, 2000).

The prevalence of ASB ranges from 29% by Geerlings et al. (2000) in 639 diabetics, to 16.5% by Alebiosu et al. (2003) in South-west Nigeria. To date the prevalence of ASB among the Ghanaian diabetic population is unknown. This study therefore seeks to establish the prevalence of ASB, antimicrobial sensitivity patterns of isolates and to determine confounding factors in type 2 diabeties (T2DM) and ASB in the Sekondi-Takoradi metropolis.

MATERIALS AND METHODS

Study area/study design: The study was undertaken at Effia-Nkwanta Regional Hospital (ENRH), Sekondi-takoradi, capital of the Western region of Ghana, the main referral medical facility serving that part of the country and surrounding regions between November, 2011 to May 2012. A cross-sectional non-probability sampling method was adopted (T2DM patients coming first at the laboratory irrespective of sex and aged 20 years and above were recruited) after their consent had been sought.

Study population: A total of 125 participants made up of 102 confirmed T2DM under routine clinical review and 23 healthy controls were recruited from the diabetic clinic and the OPD of the ENRH respectively. T2DM and control patients not being treated for any infection and not on antibiotics were included whilst pregnant women and unconfirmed diabetics with elevated sugar levels were excluded.

Ethical consideration: Ethical clearance was sought for and granted by the ethics and research committees of the ENRH and UCC. Permission was also obtained from the administrators of the hospital before the study begun. Furthermore, all the participants after thorough explanation of the rationale of the study agreed to a written informed consent and were recruited into the study. All procedures followed were in accordance with the ethical standards of the Ministry of Health, Ghana as well as the Helsinki Declaration of 1975.

Collection of blood and urine samples: After an overnight fast (8-12 h) about 2 mL of venous blood was collected into fluoride oxalate bottles, centrifuged at 1500 g for 5 min and stored at -180°C until assayed.

Using sterile, dry, wide necked, leak proof screw capped containers, midstream urine (MSU) specimen were collected for urinalysis, microscopy, culture and sensitivity. The specimens were refrigerated immediately and cultured within 2 h.

Fasting blood sugar (FBS): The plasma glucose were measured for each of the samples using the chemistry analyzer Selectra Junior (Vital Scientific, The Netherlands).

Urine culture and sensitivity (C/S): A loopful (0.002 mL) of well mixed urine sample was taken from each case using a standard calibrated loop and inoculated on a Cysteine Lactose Electrolyte-Deficient (CLED) agar. This was incubated aerobically at 37°C for 18 -24 h in an IPF 400 Precision incubator (Memmert, Germany).

Identification and counting of bacterial isolates: Bacterial colonies were identified based on their colonial morphology (color, growth size and growth pattern). Standard biochemical tests including citrate, urease, indole, catalase and coagulase tests were used for further identification. The product of the loop volume and the colony count (on CLED) gave the bacterial count. Bacterial count >1x105 CFU mL-1 was considered significant whilst a bacterial count of between 1x104-105 CFU mL-1 was considered as doubtfully significant. Bacterial count <1x104 CFU mL-1 was considered insignificant (Harding et al., 2002).

Antimicrobial susceptibility test (AST): The Kirby Bauer method (Bauer et al., 1966) was used to determine the susceptibility of the isolates to selected antimicrobial agents. Antibiotic-impregnated paper discs (Medical wire and Equipment Co. Ltd., Potley Corsham, England) containing the following antibiotics: nalidixic acid (NAL, 30 μg), gentamicin (GEN, 10 μg), tetracycline (TET, 30 μg), nitrofurantoin (NIT, 15 μg), cotrimoxazole (COT, 25 μg), ampicillin (AMP, 10 μg), cefuroxime (CRX, 30 μg) and pipemedic acid (PPA, 30 μg), were used. Fresh isolates of pure colonies were emulsified in peptone water using a sterile straight wire loop and the turbidity was adjusted to the equivalent of 0.5 McFarland’s standard. A portion of the emulsified suspension was obtained using a sterile cotton swab and a three dimensional streak was made on a Mueller Hinton agar plate. A sterile cotton swab was then used to obtain a portion of the emulsified suspension to make a three- dimensional streak on a Mueller Hinton agar plate. Based on the organism’s Gram reaction an appropriate antibiotic disc was placed on the plated ager within 15 mins of seeding and then incubated at 37°C overnight (18-24 h). A caliper was used to determine the zone of inhibition which was then compared to a standard chart to determine susceptibility categorized as sensitive or resistant as previously described by Tagoe and Desbordes (2012). A Gram negative-organism Escherichia coli (NCTC 10418) and Staphylococcus aureus [National collection of type cultures (NCTC) 6571] a Gram-positive organism, were used as controls.

Statistical analysis: GraphPad Prism version 5.00 for windows was used for statistical analysis (GraphPad software, San Diego California USA, www.graphpad.com).The results were expressed as Means±SEM. Unpaired t-test was used to compare mean values of continuous variables and χ2 was used to compare discontinuous variables. Odds ratio (OR, s) (with 95% CI) was calculated using chi-square statistical analysis.

RESULTS

Demographic and clinical features of diabetics: General characteristics of study population are shown in Table 1. Participants with ASB were older, had higher BMI, higher FBS and urine glucose levels compared to the controls (p<0.05). The prevalence of ASB was higher in the diabetic participants compared to controls though not significant (p = 0.0613). The male diabetic participants were older compared to the females (p = 0.0031) whereas the females were more obese compared to the males (p = 0.0063). The prevalence of ASB was higher in the females compared to the males though not significant (p = 0.4613).When the diabetics with ASB were compared to those without ASB, diabetics with ASB had a longer duration of diabetes compared to their counterparts without ASB (p = 0.009).

Age and sex distribution of ASB among diabetic participants: Table 2 shows the age and sex distribution of ASB among participants with diabetes. The peak incidence of ASB in males is in the sixth, seventh and eighth decade of life. In the females however, the peak incidence is found in the fourth decade of life. For the total diabetic population the peak incidence was found in the fifth decade of life.

Frequency of bacteria isolated from the urine of study participants: Table 3 represents the frequency of various bacteria isolated from the urine of study participants. E. coli were the most prevalent (15.6%) whereas E. faecalis, P. aeroginosa and C. freundii were the least prevalent (0.9%) in the diabetics with ASB. Gender wise, E. coli was more prevalent in females (16%) than in males (14.8%).

Prevalence of ASB in relation to glycaemic control: The prevalence of ASB in relation to glycaemic control is shown in Table 4. Twenty-five (30.8%) of the 81 participants with poor glycaemic control had ASB compared to 6/21 (28.6%) of subjects with good glycaemic control (p = 0.840).

The odds of developing ASB is the same in the good glycaemic and poor glycaemic groups (OR = 1.116; 95% CI = 0.3875-3.215).

Table 1: General characteristics of study participants
Image for - Asymptomatic Bacteriuria among Type 2 Diabetics in the Sekondi-takoradi Metropolis, Ghana
Data is expressed as Mean±SEM, BMI: Body mass index, ASB: Asymptomatic bacteriuria, PC: Pus cells, EC: Epithelial cells, FBS: Fasting blood glucose, HPF: High power field

Table 2: Prevalence of bacterial isolates from both controls and diabetics
Image for - Asymptomatic Bacteriuria among Type 2 Diabetics in the Sekondi-takoradi Metropolis, Ghana
CON: Coagulase negative staphylococcus

Table 3: Age and sex distribution of diabetics with ASB
Image for - Asymptomatic Bacteriuria among Type 2 Diabetics in the Sekondi-takoradi Metropolis, Ghana

Table 4: Prevalence of bacteriuria in relation to blood glucose control
Image for - Asymptomatic Bacteriuria among Type 2 Diabetics in the Sekondi-takoradi Metropolis, Ghana

Table 5: Antimicrobial sensitivity pattern of bacterial isolates of diabetics with ASB
Image for - Asymptomatic Bacteriuria among Type 2 Diabetics in the Sekondi-takoradi Metropolis, Ghana
ASB: Asymptomatic bacteriuria, NAL: Nalidixic acid, NIT: Nitrofurantoin, GEN: Gentamicin, TET: Tetracycline, CRX: Cefuroxime, PPA: Pipemidic acid, COT: Cotrimoxazole, AMP: Ampicillin

Participants with 6-10 years of diabetic history had ASB prevalence of 41.9%. However, participants who had been with diabetes for more than 20 years had the least prevalence of ASB (6.4%).

Antimicrobial sensitivity pattern of diabetic participants: The antimicrobial sensitivity pattern of the isolates from diabetic participants with ASB is shown in Table 5. E. coli, the predominant isolate was most sensitive to GEN and NIT (37.5%) and least sensitive to PPA (6.2%). K. pneumoniae the second most common isolate was 42.8% sensitive to NAL, NIT and GEN and least sensitive to PPA and AMP (33.3%). P. aeroginosa, S. aureus, E. faecalis C. freundi and coagulase negative staphylococcus (CoNS) showed 100% sensitivity to NAL, NIT and GEN.

DISCUSSION

Historically, Diabetes mellitus has been considered as a risk factor for UTI. Most cases of UTIs are asymptomatic. Furthermore, complications of UTI mostly associated with diabetics (Adeyeba et al., 2007 ). In this study we sought to establish the prevalence of ASB and also the antimicrobial sensitivity pattern of the isolated organisms as well as the factors that promote ASB in T2DM in the Sekondi-takoradi metropolis. We achieved this by undertaking urine microscopy, culture and AST, measuring BMI and recording patient’s history. The prevalence of ASB in this study was 26.4% and E. coli was the most prominent organism.

The 26.4% prevalence observed in this study is lower than the 31.7% reported by Makuyana et al. (2002) but comparable to the 26, 26.6% recorded by Geerlings et al. (2000) and Alebiosu et al. (2003), respectively. In contrast however, a lower prevalence (value) has been reported in other studies (Odetoyin et al., 2008). These percentages are the ones generally reported among female diabetic patients. Furthermore, geographical considerations and the fact that only one urine sample was used compared to the two consecutive samples used in the other studies could account for the difference.

A number of studies have reported a linkage between the duration of diabetes and ASB (Zhanel et al., 1995; Geerlings et al., 2000; Mendoza et al., 2002; Lindsay and Nicolle, 2004). This relationship was confirmed by observations made in our study; furthermore, we established that ASB was more prevalent among participants with diabetes duration of 5-10 years. In this study, the peak incidence of ASB was found in the fifth decade of life for both the female diabetic participants and the total diabetic population. Furthermore, ASB was more prevalent in the males in the sixth to eight decade of life. This supports other studies where UTI was found more commonly in the elderly (Hooton et al., 2004; Lindsay and Nicolle, 2004). Additionally, our findings suggested no significant relationship existed between ASB and glycaemic control in among our population (OR = 1.116) (Table 3), which is consistent with the findings of Odetoyin et al. (2008) and Makuyana et al. (2002) but contrary to the findings of Geerlings et al. (2000), Ishay et al. (2006) and Boroumand et al. (2006) who used HBA1c as a measure of glycaemic control.

A number of studies exploring the relationship between ASB and BMI among diabetics and non-diabetics have opined that no significant difference exists in BMI between the two groups (Geerlings et al., 2000; Ishay et al., 2006). Observations made in this study however contradict these reports. Ghanaian diet is predominantly carbohydrates in nature The predominantly carbohydrate diet of Ghanaians.

The most prominent pathogen isolated in this study was E. coli (15.6%) (Table 4). This is in contrast to the findings of Alebiosu et al. (2003) where K. pneumoniae was the most frequent isolate from diabetics with ASB. However, this observation is in agreement with the majority of reports where E. coli had been found to be the major pathogen in ASB (Olaitan, 2006; Baqai et al., 2008; Hajeri, 2008; Assel et al., 2009). E. coli is known to be the commonest cause of community Acquired Urinary Tract Infections (UTI).

Multiple drug resistance involving AMP, COT, TET, is a common occurrence in diabetics with UTI as reported by a number of studies (Alebiosu et al., 2003; Odetoyin et al., 2008). Findings in our study confirm this observation. These antibiotics could easily be bought over the counter and that could account for their high resistance among this group of patients. A study by Tagoe and Attah (2010) found that the abuse of antibiotics is prevalent in Ghana and that AMP, COT and TET are among the highly abused drugs (Tagoe and Attah, 2010).

Most of the isolates from our cultures were susceptible to NAL, NIT and GEN (Table 5). This is in line with observations made in other studies (Alebiosu et al., 2003). This implies that these antibiotics still remain the choice drugs for the treatment of ASB.

CONCLUSION

ASB is prevalent in 26.4% of the diabetic population in the Sekondi-Takoradi metropolis and E. coli is the most prevalent isolate. Furthermore, factors such as duration of diabetes and advanced age predispose diabetics to ASB even though GEN, NAL and NIT proved the drugs of choice for this diabetic population. It is therefore important for diabetologists to ensure that urine cultures are periodically requested for diabetics even when there are no symptoms. This will serve as a precautionary measure, especially for those at risk.

ACKNOWLEDGMENT

The authors would like to express their heartfelt appreciation to the clinicians, nurses, biomedical scientists (both at the ENRH laboratory and the Public Health Laboratory) and patients of the diabetic clinic of the ENRH, Takoradi for their immense contributions in making this work a success.

REFERENCES

1:  Adeyeba, O.A., P.O. Omosigho and Y.O. Adesiji, 2007. Bacterial urinary tract infections in patients with diabetes mellitus. Int. J. Trop. Med., 2: 89-92.
Direct Link  |  

2:  Alebiosu, C.O., O.A. Osinupebi and F.A. Olajubu, 2003. Significant asymptomatic bacteriuria among Nigerian type 2 diabetics. J. Natl. Med. Assoc., 95: 344-349.
Direct Link  |  

3:  Assel, M.T., F.M. Al-Meer, M.G. Al-Kuwari and M.F.S. Ismail, 2009. Prevalence and predictor of asymptomatic bacteriuria among pregnant women attending Primary health care in Qatar Middle East. J. Fam. Med., 4: 14-17.
Direct Link  |  

4:  Baqai, R., M. Aziz and G. Rasool, 2008. Urinary tract infection in diabetic patients and biofilm formation of uropathogens. Infect. Dis. J. Pak., 17: 21-24.

5:  Bauer, A.W., W.M.M. Kirby, J.C. Sherris and M. Turck, 1966. Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol., 45: 493-496.
CrossRef  |  PubMed  |  Direct Link  |  

6:  Boroumand, M.A., L. Sam, S.H. Abbasi, M. Salarifar, E. Kassaian and S. Forghani, 2006. Asymptomatic bacteriuria in type 2 Iranian diabetic women: A cross sectional study. BMC Women's Health, Vol. 6.
CrossRef  |  Direct Link  |  

7:  Carton, J.A., J.A. Maradona, F.J. Nuno, R. Fernandez-Alvarez, F. Perez-Gonzalez and V. Asensi, 1992. Diabetes mellitus and bacteraemia: A comparative study between diabetic and non-diabetic patients. Eur. J. Med., 1: 281-287.
PubMed  |  Direct Link  |  

8:  Geerlings, S.E., R.P. Stolk, M.J. Camps, P.M. Netten and J.B. Hoekstra et al., 2000. Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Care., 23: 744-749.
CrossRef  |  

9:  Hajeri, A., 2008. When to treat asymptomatic bacteriuria. Bahrain Med. Bull., 30: 1-4.

10:  Harding, G.K., G.G. Zhanel, L.E. Nicolle and M. Cheang, 2002. Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N. Eng. J. Med., 347: 1576-1583.

11:  Hooton, T.M., R. Besser, B. Foxman, T.R. Fritsche and L.E. Nicolle, 2004. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: A proposed approach to empirical therapy. Clin. Infect. Dis., 39: 75-80.
CrossRef  |  

12:  Ishay, A., I. Lavi and R. Luboshitzky, 2006. Prevalence mellitus and risk factors for asymptomatic bacteriuria in women with type 2 diabetes. Diabet. Med., 23: 185-188.
Direct Link  |  

13:  Lindsay, E. and L.E. Nicolle, 2004. Diagnosis and treatment of asymptomatic bacteriuria in adults. J. Med. Clin. North Am., 80: 600-618.

14:  Makuyana, D., D. Mhlabi, M. Chipfupa, T. Munyombwe and L. Gwanzura, 2002. Asymptomatic bacteriuria among outpatients with diabetes mellitus in an urban black population. Cent. Afr. J. Med., 48: 78-82.
PubMed  |  Direct Link  |  

15:  Mendoza, T., M.G. de los Rios, M. Lafourcade, C. Soto, P. Durruty and M. Alvo, 2002. Asymptomatic bacteriuria in type 2 diabetics women. Rev. Med. Chil., 130: 1001-1007.
PubMed  |  Direct Link  |  

16:  Nicolle, L.E., 2000. Asymptomatic bacteriuria in diabetic women. Diabetes Care, 23: 722-723.
Direct Link  |  

17:  Odetoyin, W.B., A.O. Aboderin, R.T. Ikem, B.A. Kolawole and A.O. Oyelese, 2008. Asymptomatic bacteriuria in patients with diabetes mellitus in Ile-Iffe, South-West Nigeria. East Afr. Med. J., 85: 18-23.
Direct Link  |  

18:  Olaitan, J.O., 2006. Asymptomatic bacteriuria in female students population of a Nigerian university. Internet J. Microbiol., 2: 1-7.
Direct Link  |  

19:  Pozzilli, P. and R.D.G. Leslie, 1994. Infections and diabetes: Mechanisms and prospects for prevention. Diabetes Med., 11: 935-941.
CrossRef  |  

20:  Tagoe, D.N.A. and C.O. Attah, 2010. A study of antibiotic use and abuse in Ghana: A case study of the cape coast metropolis. Internet J. Health, Vol. 11, No. 2.
CrossRef  |  Direct Link  |  

21:  Tagoe, D.N.A. and K.K. Desbordes, 2012. Investigating potential sources of transmission of healthcare-associated infections in a regional hospital, Ghana. Int. J. Applied Basic Med. Res., 2: 20-24.
CrossRef  |  Direct Link  |  

22:  Zhanel, G.G., G.K. Harding and L.E. Nicolle, 1991. Asymptomatic bacteriuria in patients with diabetes mellitus. Rev. Infect. Dis., 13: 150-154.
CrossRef  |  

23:  Zhanel, G.G., L.E. Nicolle and G.K.M. Harding, 1995. Prevalence of asymptomatic bacteriuria and associated host factors in women with diabetes mellitus. The manitoba diabetic urinary infection study group. Clin. Infect. Dis., 21: 316-322.
CrossRef  |  

©  2022 Science Alert. All Rights Reserved